Page last updated: 2024-08-24

iopamidol and Dyslipidemia

iopamidol has been researched along with Dyslipidemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inoue, K; Kimura, F; Kozawa, E; Matsuo, Y; Mizukoshi, W; Nakajima, T; Sakai, F1
Aihara, H; Aonuma, K; Endo, M; Kawano, S; Maruyama, H; Saito, T; Sakai, S; Sato, A; Shimojo, N; Tajiri, K; Watanabe, S1

Other Studies

2 other study(ies) available for iopamidol and Dyslipidemia

ArticleYear
CT features of myocardial fat and correlation with clinical background in patients without cardiac disease.
    Japanese journal of radiology, 2013, Volume: 31, Issue:7

    Topics: Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Body Mass Index; Cardiac-Gated Imaging Techniques; Contrast Media; Diabetes Complications; Dyslipidemias; Female; Humans; Hypertension; Iohexol; Iopamidol; Male; Middle Aged; Myocardium; Tomography, X-Ray Computed

2013
Prediction of chronic renal insufficiency after coronary angiography by an early increase in oxidative stress and decrease in glomerular filtration rate.
    Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:2

    Topics: Acetylglucosaminidase; Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Diabetes Mellitus; Dyslipidemias; F2-Isoprostanes; Female; Glomerular Filtration Rate; Humans; Hypertension; Iopamidol; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Oxidative Stress; Prospective Studies; Risk Factors

2011